Eiger BioPharmaceuticals Inc. (EIGR) Slipped -7.97% or -0.87 To Price $10.04 On Monday


Eiger BioPharmaceuticals Inc. (EIGR) slipped -7.97% or -0.87 to $10.04. It is close to 81146 shares traded, which is 47.69% compare to the average total volume 170167. The market cap of EIGR is $143.01 million. The year to date change is -36.51%. The 52 week price range is from $7.46 to $18.0. Price of EIGR have changed -6.67% during last week. It have changed 12.01% over last month, 13.65% over last 3 months, 9.10% over last 6 months and 0.55% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 11.69. It is 16.43% above current price. The 200-day Moving Averages for EIGR is 11.04. It is 9.96% above current price. The 52-week High is 18.0. It is 79.28% from the current price. The 52-week Low is 7.46. It is -25.70% from current price.

There are some statistics of EIGR. It is has market cap $143.01 million. The share outstanding is 14.24 million. The average volume is 170167. The percent of top 15 Institution holding is 95.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -110.96%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -66.45%.


Tags:

Share this post